X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (55626) 55626
Dissertation (282) 282
Book Chapter (171) 171
Publication (61) 61
Newsletter (50) 50
Magazine Article (48) 48
Book / eBook (28) 28
Conference Proceeding (25) 25
Newspaper Article (16) 16
Book Review (13) 13
Web Resource (12) 12
Paper (2) 2
Reference (2) 2
Streaming Video (2) 2
Data Set (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (32660) 32660
science & technology (28740) 28740
life sciences & biomedicine (27770) 27770
male (23511) 23511
humans (21215) 21215
rats (18123) 18123
angiotensin ii - pharmacology (17213) 17213
angiotensin ii (17004) 17004
female (12740) 12740
blood pressure - drug effects (9207) 9207
cardiovascular system & cardiology (8941) 8941
angiotensin (8436) 8436
angiotensin ii - metabolism (7035) 7035
hypertension (6549) 6549
peripheral vascular disease (6183) 6183
middle aged (5807) 5807
adult (5320) 5320
pharmacology & pharmacy (5072) 5072
rats, sprague-dawley (5046) 5046
blood pressure (5008) 5008
mice (4740) 4740
angiotensin ii - physiology (4663) 4663
cells, cultured (4649) 4649
physiology (4485) 4485
hypertension - drug therapy (4452) 4452
angiotensin ii type 1 receptor blockers - therapeutic use (4361) 4361
cardiac & cardiovascular systems (4284) 4284
angiotensin ii - blood (4278) 4278
hypertension - physiopathology (4180) 4180
renin - blood (4114) 4114
aged (3870) 3870
dose-response relationship, drug (3822) 3822
time factors (3283) 3283
in vitro techniques (3250) 3250
angiotensin-converting enzyme inhibitors - therapeutic use (3240) 3240
angiotensin ii type 1 receptor blockers - pharmacology (3214) 3214
angiotensin receptor antagonists (2994) 2994
rats, wistar (2924) 2924
angiotensin ii - antagonists & inhibitors (2890) 2890
renin-angiotensin system (2888) 2888
disease models, animal (2846) 2846
renin-angiotensin system - drug effects (2795) 2795
tetrazoles - pharmacology (2772) 2772
dogs (2625) 2625
biochemistry & molecular biology (2519) 2519
rats, inbred strains (2494) 2494
antihypertensive agents - therapeutic use (2493) 2493
losartan (2419) 2419
renin-angiotensin system - physiology (2414) 2414
urology & nephrology (2340) 2340
imidazoles - pharmacology (2288) 2288
angiotensin-converting enzyme inhibitors - pharmacology (2280) 2280
rabbits (2268) 2268
endocrinology & metabolism (2228) 2228
norepinephrine - pharmacology (2223) 2223
losartan - pharmacology (2132) 2132
signal transduction (2106) 2106
cell biology (2092) 2092
vasoconstrictor agents - pharmacology (2090) 2090
receptors, angiotensin - metabolism (2076) 2076
antihypertensive agents - pharmacology (2057) 2057
angiotensin ii - administration & dosage (2038) 2038
kidney - drug effects (2002) 2002
treatment outcome (1975) 1975
receptor, angiotensin, type 1 - metabolism (1970) 1970
aldosterone - blood (1932) 1932
research (1926) 1926
tetrazoles - therapeutic use (1920) 1920
heart rate - drug effects (1905) 1905
mice, inbred c57bl (1899) 1899
physiological aspects (1858) 1858
hypertension - metabolism (1851) 1851
risk factors (1815) 1815
angiotensin ii - analogs & derivatives (1813) 1813
muscle, smooth, vascular - drug effects (1808) 1808
medicine, research & experimental (1790) 1790
kidney - metabolism (1782) 1782
research & experimental medicine (1767) 1767
renin (1741) 1741
blood pressure - physiology (1704) 1704
oxidative stress (1674) 1674
drug therapy, combination (1670) 1670
heart failure (1647) 1647
rats, inbred shr (1637) 1637
myocardium - metabolism (1607) 1607
calcium - metabolism (1596) 1596
research article (1575) 1575
cardiovascular system (1556) 1556
neurosciences & neurology (1556) 1556
rodents (1540) 1540
kinetics (1539) 1539
rna, messenger - metabolism (1529) 1529
neurosciences (1519) 1519
gene expression (1507) 1507
pregnancy (1499) 1499
mice, knockout (1468) 1468
fibrosis (1450) 1450
nitric oxide (1438) 1438
inflammation (1424) 1424
receptor, angiotensin, type 1 (1420) 1420
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (52467) 52467
Japanese (1636) 1636
German (929) 929
Chinese (685) 685
French (620) 620
Russian (508) 508
Italian (339) 339
Spanish (291) 291
Portuguese (217) 217
Polish (132) 132
Czech (56) 56
Romanian (40) 40
Danish (38) 38
Dutch (30) 30
Hungarian (30) 30
Korean (29) 29
Swedish (27) 27
Slovak (20) 20
Norwegian (17) 17
Turkish (17) 17
Ukrainian (17) 17
Bulgarian (16) 16
Finnish (9) 9
Hebrew (8) 8
Serbian (5) 5
Croatian (4) 4
Persian (4) 4
Lithuanian (2) 2
Slovenian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biomaterials, ISSN 0142-9612, 2014, Volume 35, Issue 29, pp. 8450 - 8466
Abstract A multifunctional copolymer–anticancer conjugate chitosan-graft-polyethyleneimine-candesartan (CPC) containing low molecular weight chitosan (CS)... 
Advanced Basic Science | Dentistry | Wild type p53 | Co-delivery | Candesartan | Angiotensin II type 1 receptor targeting | Multifunctional copolymer–anticancer conjugate | Tumor anti-angiogenesis therapy | Multifunctional copolymer-anticancer conjugate | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | Neoplasms - metabolism | Genetic Therapy | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | DNA - therapeutic use | Male | Benzimidazoles - chemistry | Angiotensin II Type 1 Receptor Blockers - metabolism | Drug Delivery Systems | Tetrazoles - metabolism | Genes, p53 | Neoplasms - therapy | Benzimidazoles - administration & dosage | Neoplasms - genetics | Tetrazoles - chemistry | Tetrazoles - administration & dosage | Polyethyleneimine - chemistry | Chitosan - analogs & derivatives | Chitosan - metabolism | Neovascularization, Pathologic - therapy | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Benzimidazoles - therapeutic use | Gene Transfer Techniques | Polyethyleneimine - metabolism | Angiotensin II Type 1 Receptor Blockers - chemistry | DNA - administration & dosage | Neoplasms - blood supply | DNA - genetics | Polyethyleneimine - analogs & derivatives | Animals | Chitosan - chemistry | Benzimidazoles - metabolism | Receptor, Angiotensin, Type 1 - metabolism | Cell Line, Tumor | Neovascularization, Pathologic - genetics | Tetrazoles - therapeutic use | Mice, Inbred BALB C | RNA | Political corruption | Genes | Analysis | Angiotensin | Genetic research | Genetic aspects | Pharmaceutical industry | Tumor proteins | Health aspects | Vascular endothelial growth factor | Cancer | Drugs | Therapy | Cadmium | Nanostructure | Buffers | Density | Tumors
Journal Article
Brain Research, ISSN 0006-8993, 2010, Volume 1368, pp. 231 - 238
Abstract Sleep apnea is characterized by increased sympathetic activity and is associated with systemic hypertension. Angiotensin (Ang) peptides have... 
Neurology | Intermittent hypoxia | Hypertension | Renin–angiotensin system | Sympathetic activity | Angiotensin-(1–7) | Renin-angiotensin system | Angiotensin-(1-7) | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Sleep Apnea Syndromes - physiopathology | Angiotensin II - administration & dosage | Angiotensin Receptor Antagonists - pharmacology | Imidazoles - administration & dosage | Male | Peptide Fragments - pharmacology | Angiotensin II Type 1 Receptor Blockers - pharmacology | Angiotensin II Type 2 Receptor Blockers - pharmacology | Hypertension - etiology | Hypertension - prevention & control | Blood Pressure - drug effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Disease Models, Animal | Angiotensin II - pharmacology | Pyridines - administration & dosage | Microinjections | Peptide Fragments - administration & dosage | Losartan - pharmacology | Rats | Imidazoles - pharmacology | Angiotensin II - analogs & derivatives | Rats, Sprague-Dawley | Sleep Apnea Syndromes - complications | Paraventricular Hypothalamic Nucleus - drug effects | Animals | Angiotensin II Type 2 Receptor Blockers - administration & dosage | Pyridines - pharmacology | Losartan - administration & dosage | Angiotensin Receptor Antagonists - administration & dosage | Neurons | Carbon dioxide | Antagonists | Hypothalamus | Paraventricular nucleus | Muscimol | Sympathetic nervous system | Telemetry | Angiotensin receptors | Sleep disorders | Apnea | gamma -Aminobutyric acid A receptors | Angiotensin | Hypoxia | Blood pressure | cardiovascular regulation | peptides: anatomy and physiology | sympathetic activity | angiotensin-(1-7) | hypothalamic-pituitary-adrenal regulation | intermittent hypoxia | hypertension | renin-angiotensin system
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2017, Volume 377, Issue 5, pp. 419 - 430
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2009, Volume 361, Issue 1, pp. 40 - 51
This study aimed to determine whether early administration of drugs that block the renin–angiotensin system slows the progression of change in glomerular... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Retina - drug effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Male | Albuminuria | Angiotensin II Type 1 Receptor Blockers - pharmacology | Enalapril - therapeutic use | Enalapril - adverse effects | Mesangial Cells - drug effects | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Diabetic Nephropathies - prevention & control | Double-Blind Method | Diabetes Mellitus, Type 1 - physiopathology | Kidney Glomerulus - drug effects | Diabetes Mellitus, Type 1 - pathology | Kaplan-Meier Estimate | Losartan - pharmacology | Logistic Models | Kidney Glomerulus - pathology | Disease Progression | Diabetes Mellitus, Type 1 - drug therapy | Diabetic Retinopathy - prevention & control | Enalapril - pharmacology | Losartan - therapeutic use | Mesangial Cells - pathology | Losartan - adverse effects | Renin-Angiotensin System - drug effects | Retina - pathology | Diabetic retinopathy | Control | Usage | Enalapril | Type 1 diabetes | Patient outcomes | Losartan | Enalaprilat | Drug therapy | Kidneys | Diabetes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Brain Research, ISSN 0006-8993, 2014, Volume 1583, Issue 1, pp. 132 - 140
Journal Article